Pipeline

Debiopharm International’s projects cover all molecule type proteins,
peptides, small molecules

Discovery Preclinical Phase I Phase II Phase III
Head & Neck Cancer
SMAC mimetic
Non-Hodgkin Lymphoma
Anti-CD37 ADC
odd
Oncology
FGFR1,2,3 inhibitor
odd/ft
NSCLC
SMAC mimetic
Advanced melanoma resistant
GnRH
Medullary thyroid cancer
Minigastrin-Lu177
Oncology
Wee1 kinase inhibitor
ABSSSI
FabI inhibitor
ft/qidp
Infectious diseases
Sample prep. Technology
Bone & joint infections
FabI inhibitor
odd/ft/qidp
GI disorders
Cyclophilin inhibitor
N.gonorrhoeae, H. pylori
Fabl inhibitor
carb-x
Enteric species
Fabl inhibitor
*in combination with avelumab
**in combination with nivolumab
odd
Orphan Drug Designation
ft
Fast-Track
qidp
Qualified Infectious Disease Product
carb-x
CARB-X
Infectious disease
Oncology

Our commercialized products